PDCD1 and cutaneous melanoma: A similar study by Gide et al. [59] used mass cytometry to study the immune cell clusters in skin melanoma patients who had received either single (anti-PD-1) or combinatorial immunotherapy (anti-PD-1 plus anti-CTLA-4).